NGS Banner


Hear from our two AMP 2022 guest speakers about their experience utilising OGT’s SureSeq™ myeloid NGS research solutions in their genomic laboratories to detect key aberrations in myeloid malignancies, including CEBPA gene variants, FLT3-ITDS, and KMT2A-PTDs, among others.

Talk #1

Comparative analysis of testing methods used for the detection of internal tandem duplications (ITDs) in the KMT2A/MLL gene

Presented by José-Mario Capo-Chichi Ph.D., FCCMG, FACMG

Talk #2

Comparison of mutation profiles in MDS and AML: A single site experience

Presented by Elizabeth McCready Ph.D., FCCMG


SureSeq: For Research Use Only; Not for Use in Diagnostic Procedures. 

CTA Icon

Stay up-to-date with the latest news from OGT, including new products, support resources, and our DNA Dispatch newsletter